Company profile for Halozyme Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. Our research targets the extracellular matrix, an area outside the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, we have developed unique scientific expertise th...
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. Our research targets the extracellular matrix, an area outside the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, we have developed unique scientific expertise that allows us to pursue this target-rich environment for the development of future therapies. The company's research focuses primarily on human enzymes that alter the extracellular matrix.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11388 Sorrento Valley Road San Diego, CA 92121
Telephone
Telephone
858.794.8889
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/halozyme-to-participate-in-the-8th-annual-evercore-healthcare-conference-302625341.html

PR NEWSWIRE
25 Nov 2025

https://www.prnewswire.com/news-releases/halozyme-completes-acquisition-of-elektrofi-expanding-breadth-of-offerings-in-drug-delivery-302618579.html

PR NEWSWIRE
18 Nov 2025

https://www.prnewswire.com/news-releases/merus-and-halozyme-enter-global-collaboration-and-license-agreement-to-develop-subcutaneous-formulation-of-petosemtamab-302616859.html

PR NEWSWIRE
17 Nov 2025

https://www.prnewswire.com/news-releases/halozyme-therapeutics-inc-announces-proposed-offering-of-650-million-of-convertible-senior-notes-due-2031-and-650-million-of-convertible-senior-notes-due-2032-302606142.html

PR NEWSWIRE
05 Nov 2025

https://www.prnewswire.com/news-releases/halozyme-raises-2025-financial-guidance-and-reports-strong-third-quarter-2025-financial-and-operating-results-302603066.html

PR NEWSWIRE
04 Nov 2025

https://www.prnewswire.com/news-releases/halozyme-to-report-third-quarter-2025-financial-and-operating-results-302589996.html

PR NEWSWIRE
21 Oct 2025

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Halozyme Therapeutics and get a quotation

Halozyme Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of ENHANZE DRUG PRODUCT bulk with DMF offered by Halozyme Therapeutics

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty